In this section : Covid-19
Molnupiravir
Sotrovimab
Conscious Proning
Covid-19 Basics
Remdesivir
Thromboprophylaxis
Identifying Patients in the Highest Risk Groups
Steroids for Patients with Covid-19 Infection
IL-6 Inhibitors – Tocilizumab or Sarilumab
Baricitinib
Paxlovid (Nirmatrelvir/Ritonavir)
Covid-19 Sick Day Rules for Patients with Primary Adrenal Insufficiency
Remdesivir
Last updated 26th June 2023
Please ensure you have read the information on the Covid-19 Basics page before proceeding.
Remdesivir is no longer a first line choice for patients with Covid-19 infection. Please discuss with relevant consultant and pharmacist before prescribing.
If the choice to prescribe is made, the following chart applies:
For more information on Paxlovid suitability, please visit the Paxlovid( Nirmatrelvir/Ritonavir) page
Availability
- For patients not requiring oxygen, available from Pharmacy during usual opening hours (0900 – 1700)
- For patients who are on low flow oxygen, available from Pharmacy during usual opening hours (0900 – 1700) or can be obtained urgently until 2200 if necessary by contacting the on-call pharmacist
Links
- NICE COVID-19 rapid guideline: Managing COVID-19
- SEHD Covid Therapeutic Alert 2023 1 – Publication of NICE Multiple Technology Appraisal (MTA) – Treatment Recommendations for Covid 19
Content by Alison Moore